vTv Therapeutics' sickle cell asset HPPD gains FDA orphan drug status
FDA orphan drug status for vTv Therapeutics' sickle cell asset HPPD is a regulatory catalyst.
What changed
FDA orphan drug status for vTv Therapeutics' sickle cell asset HPPD is a regulatory catalyst.
Why it matters
FDA orphan drug status for vTv Therapeutics' sickle cell asset HPPD is a regulatory catalyst. — impact context not separately stored; see What changed.
← Dashboard
Oct 08, 2026 04:40 AM ET